Iwamoto, Naoki
Chiba, Ko
Sato, Shuntaro
Shiraishi, Kazuteru
Watanabe, Kounosuke
Oki, Nozomi
Okada, Akitomo
Koga, Tomohiro
Kawashiri, Shin-ya
Tamai, Mami
Hosogaya, Naoki
Furuyama, Masako
Kobayashi, Makiko
Saito, Kengo
Okubo, Naoki
Uetani, Masataka
Osaki, Makoto
Kawakami, Atsushi
Article History
Received: 29 June 2022
Accepted: 20 November 2022
First Online: 7 December 2022
Declarations
:
: The study protocol was approved by the Nagasaki University Hospital Clinical Research Ethics Committee and the Clinical Research Review Board in Nagasaki University, and the study was conducted in accordance with the principles of the Declaration of Helsinki and Clinical Trials Act (since February 2019). All patients provided written informed consent.
: Not applicable.
: Naoki Iwamoto and Atsushi Kawakami have received speaker’s bureau fees and grant/research support from Daiichi Sankyo Co., Ltd. Ko Chiba has received speaker’s bureau fees from Daiichi Sankyo Co., Ltd. Shuntaro Sato, Kazuteru Shiraishi, Kounosuke Watanabe, Nozomi Oki, Akitomo Okada, Tomohiro Koga, Shin-ya Kawashiri, Mami Tamai, Naoki Hosogaya, and Masako Furuyama declare that they have no competing interests. Makiko Kobayashi was an employee of Daiichi Sankyo Co., Ltd., during the conduct of this study. Kengo Saito and Naoki Okubo are employees of Daiichi Sankyo Co., Ltd. Masataka Uetani and Makoto Osaki have received lecture fees from Daiichi Sankyo Co., Ltd.